Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Depression in patients with HIV infection
Autore:
Penzak, SR; Reddy, YS; Grimsley, SR;
Indirizzi:
Mercer Univ, So Sch Pharm, Dept Pharm Practice, Atlanta, GA 30341 USA Mercer Univ Atlanta GA USA 30341 pt Pharm Practice, Atlanta, GA 30341 USA Ohio State Univ, Columbus, OH 43210 USA Ohio State Univ Columbus OH USA 43210 State Univ, Columbus, OH 43210 USA
Titolo Testata:
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
fascicolo: 4, volume: 57, anno: 2000,
pagine: 376 - 386
SICI:
1079-2082(20000215)57:4<376:DIPWHI>2.0.ZU;2-T
Fonte:
ISI
Lingua:
ENG
Soggetto:
HUMAN-IMMUNODEFICIENCY-VIRUS; BASE-LINE ASSESSMENT; MAJOR DEPRESSION; IMMUNE STATUS; IN-VITRO; POSITIVE PATIENTS; SEROPOSITIVE MEN; HOMOSEXUAL MEN; AIDS; FLUOXETINE;
Keywords:
androgens; antidepressants; depression; dosage schedules; epidemiology; HIV infections; protocols; psychotherapeutic agents;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Life Sciences
Citazioni:
89
Recensione:
Indirizzi per estratti:
Indirizzo: Penzak, SR Mercer Univ, So Sch Pharm, Dept Pharm Practice, 3001 Mercer Univ Dr, Atlanta, GA 30341 USA Mercer Univ 3001 Mercer Univ Dr Atlanta GA USA 30341 30341 USA
Citazione:
S.R. Penzak et al., "Depression in patients with HIV infection", AM J HEAL S, 57(4), 2000, pp. 376-386

Abstract

The epidemiology, clinical features, and drug treatment of depression in HIV-infected patients are discussed. The lifetime prevalence of depression in patients infected with HIV has been estimated at 22-45%. The signs and symptoms of depression are similar inHIV-infected and noninfected patients, but patients with HIV infection maymore frequently have sleep and appetite disturbances. Diagnosis should focus on affective or cognitive depression symptoms that reflect mood state alone. Patients with a history of depression, homosexual men, women, and i.v.drug abusers are among HIV-infected individuals who may be at increased risk for depression. Depression may alter the course of HIV infection by impairing immune function or influencing behavior. Depression my contribute to nonadherence to therapy. Antidepressant therapy is effective in most HIV-positive patients with major depression. Tricyclic antidepressants (TCAs) have produced response rates as high as 89%, but their usefulness has been limited by adverse effects. Selective serotonin-reuptake inhibitors and other non-TCAs have also demonstrated efficacy and are generally better tolerated. Psychostimulants have improved mood, cognition, and energy level, and androgens have been used for their anabolic effects. The systemic concentrations of antidepressants may be altered by coadministered drugs that affect their cytochrome P-450 isoenzyme-mediated metabolism; in turn, the metabolismand toxicity of certain antiretrovirals may be affected by antidepressants. Guidelines on the treatment of depression in the general population may be applied to patients with HIV infection. Depressive disorders are prevalent among patients with HIV infection but often respond to a variety of treatments.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/07/20 alle ore 07:26:07